DENVER—About 100 Colorado children are expected to participate in a clinical trial for a swine flu vaccine.
Dr. Isaac Melamed of IMMUNOe 1st International Research Centers in the Denver suburb of Thornton plans to begin trials this week for pharmaceutical manufacturer Novartis.
Children between ages 3 and 8 are eligible.
The Denver study is part of a larger clinical trial at about 30 sites in the U.S. and Mexico.
Other drug companies also plan trials using a “seed virus” from the federal Centers for Disease Control and Prevention in Atlanta.
Dr. Matthew F. Daley, a professor at the University of Colorado Denver and a pediatrician at The Children’s Hospital, says the vaccine is expected to be safe.
———
Information from: The Denver Post,
